Case File
efta-01874465DOJ Data Set 10OtherEFTA01874465
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01874465
Pages
1
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
To:
Jeffrey EpsteinUeevacationagmail.comj
From:
Jeffrey Epstein
Sent
Fri 7/6/2012 11:01:24 AM
The IRS has advanced many theories to challenge the gift and estate tax savings occasioned by
the use of family entities and grantor trusts in estate planning. Until recently, most IRS arguments
had been rather unsuccessful. However, the IRS discovered a potent weapon in IRC § 2036(a),
which provides that the value of the gross estate includes the value of all property to the extent
the decedent has made a transfer but has retained (i) the possession or enjoyment of, or the right
to income from, the property, or (ii) the right, either alone or in conjunction with any person, to
designate the persons who shall possess or enjoy the property or the income therefrom.
The IRS has been successful in arguing that IRC § 2036(a) requires the inclusion in the
decedent's estate of (i) partnership assets if the decedent continued to derive benefits from the
partnership, or of (ii) trust assets, if the decedent continued to receive distributions, disguised in
the form of a note, from assets sold to a "defective" grantor trust. The IRS has been most
successful where the transactions with not imbued with a sufficient quantum of non-tax
objectives, or the economics of the transaction were questionable, most often because the grantor
had not left himself with sufficient assets to live according to his accustomed standard without
receiving partnership (or trust) distributions.
***********************************************************
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA_R1_00282619
EFTA01874465
Technical Artifacts (1)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.